Efficacy of Laparoscopic Mini Gastric Bypass for Obesity and Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis

• Published in: Gastroenterology research and practice Vol. 2015; no. 2015; pp. 1 - 13
• Main Authors: Min, Zhijun, Zhang, Peng, Zhuang, Biao, Xu, Ming, Ye, Min, Huang, Ao, Quan, Yingjun, Yu, Bo
• Format: Journal Article
• Language: English
• Published: Cairo, Egypt Hindawi Publishing Corporation 01.01.2015; John Wiley & Sons, Inc; Hindawi Limited
• Subjects: Care and treatment; Chronic illnesses; Confidence intervals; Diabetes; Gastric bypass; Gastrointestinal surgery; Hospitals; Hyperglycemia; Laparoscopic surgery; Laparoscopy; Meta-analysis; Metabolism; Methods; Mortality; Obesity; Review; Software reviews; Studies; Surgical outcomes; Type 2 diabetes; Weight control
• ISSN: 1687-6121; 1687-630X
• DOI: 10.1155/2015/152852

Background. Controversies on the utility of laparoscopic mini gastric bypass (LMGB) in weight loss and type 2 diabetes mellitus (T2DM) control still exist. Methods. We conducted a comprehensive literature search of PubMed, EMBASE, and Cochrane Library. Review Manager was used to perform the meta-analysis and the weighted mean difference (WMD) and/or odds ratio with 95% confidence interval (95% CI) were used to evaluate the overall size effect. Results. The literature search identified 16 studies for systematic review and 15 articles for meta-analysis. Compared with LAGB, LSG, and LRYGB, LMGB showed significant weight loss [WMD, −6.58 (95% CI, −9.37, −3.79), P<0.01 (LAGB); 2.86 (95% CI, 1.40, 5.83), P=0.004 (LSG); 10.33 (95% CI, 4.30, 16.36), P<0.01 (LRYGB)] and comparable/higher T2DM remission results [86.2% versus 55.6%, P=0.06 (LAGB); 89.1% versus 76.3%, P=0.004 (LAGB); 93.4% versus 77.6%, P=0.006 (LAGB)]; LMGB also had shorter learning curve and less operation time than LRYGB [WMD, −35.2 (95% CI, −46.94, −23.46)]. Conclusions. LMGB appeared to be effective in weight loss and T2DM remission and noninferior to other bariatric surgeries. However, clinical utility of LMGB needs to be further validated by future prospective randomized controlled trials.